We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Masimo Launches Masimo SafetyNet-Open to Fight Coronavirus
Read MoreHide Full Article
Masimo Corporation (MASI - Free Report) recently launched Masimo SafetyNet-Open, which has been designed to help businesses, governments and schools manage employee and student health and safety better during COVID-19.
This is expected to strengthen the company’s foothold in the non-invasive patient monitoring space.
More About Masimo SafetyNet-Open
In March 2020, Masimo launched the Masimo SafetyNet-COVID-19 remote patient-monitoring solution, which is being utilized by hospitals to ensure the safety of both patients and frontline workers. Masimo SafetyNet-Open will enable its clients to meet the challenge of reopening responsibly and safely with a wide-ranging, flexible and easy-to-implement continuous monitoring solution, which, along with clinical guidance from partner hospitals, would ensure prevention, early diagnosis and recovery monitoring.
Masimo SafetyNet-Open does not just act as a simple screening check at the workplace entrance. It helps in coordination of the continuous monitoring of people through an array of sensors and an app. Masimo SafetyNet-Open can help organizations better figure out patterns that may support contact tracing on the back of a centralized dashboard. The system components work jointly to offer integrated and secure monitoring that organizations can utilize to identify when additional action may be required.
Recent Developments
Masimo has seen a plethora of developments lately.
In March, the company and University Hospitals collaborated to implement Masimo SafetyNet to help clinicians monitor patients remotely. Notably, Masimo SafetyNet is a telehealth solution that combines the Radius PPG pulse oximetry. The solution functions through Masimo SET Measure-through Motion and Low Perfusion technology, and Doctella.
In the same month, the company inked a deal with Imprivata with respect to the integration of Imprivata Medical Device Access into Masimo’s Hospital Automation solutions that feature the Root Patient Monitoring and Connectivity Platform.
Market Prospects
Per a report by Grand View Research, the global remote patient-monitoring system market is anticipated to reach $1.8 billion by 2026, witnessing a CAGR of 13.5% during the forecast period (2019-2026). Hence, this launch is well-timed.
Price Performance
Over the past three months, shares of this company have surged 52.3% compared with the industry’s growth of 46.2%.
Zacks Rank and Key Picks
Masimo currently holds a Zacks Rank #3 (Hold).
Some better-ranked stocks from the broader medical space are Laboratory Corporation of America Holdings (LH - Free Report) , Surmodics (SRDX - Free Report) and HMS Holdings .
Surmodics’ long-term earnings growth rate is estimated at 10%. The company presently carries a Zacks Rank #1.
HMS Holdings’ long-term earnings growth rate is estimated at 10%. It currently carries a Zacks Rank #2.
Zacks Top 10 Stocks for 2020
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?
Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Image: Bigstock
Masimo Launches Masimo SafetyNet-Open to Fight Coronavirus
Masimo Corporation (MASI - Free Report) recently launched Masimo SafetyNet-Open, which has been designed to help businesses, governments and schools manage employee and student health and safety better during COVID-19.
This is expected to strengthen the company’s foothold in the non-invasive patient monitoring space.
More About Masimo SafetyNet-Open
In March 2020, Masimo launched the Masimo SafetyNet-COVID-19 remote patient-monitoring solution, which is being utilized by hospitals to ensure the safety of both patients and frontline workers. Masimo SafetyNet-Open will enable its clients to meet the challenge of reopening responsibly and safely with a wide-ranging, flexible and easy-to-implement continuous monitoring solution, which, along with clinical guidance from partner hospitals, would ensure prevention, early diagnosis and recovery monitoring.
Masimo SafetyNet-Open does not just act as a simple screening check at the workplace entrance. It helps in coordination of the continuous monitoring of people through an array of sensors and an app. Masimo SafetyNet-Open can help organizations better figure out patterns that may support contact tracing on the back of a centralized dashboard. The system components work jointly to offer integrated and secure monitoring that organizations can utilize to identify when additional action may be required.
Recent Developments
Masimo has seen a plethora of developments lately.
In March, the company and University Hospitals collaborated to implement Masimo SafetyNet to help clinicians monitor patients remotely. Notably, Masimo SafetyNet is a telehealth solution that combines the Radius PPG pulse oximetry. The solution functions through Masimo SET Measure-through Motion and Low Perfusion technology, and Doctella.
In the same month, the company inked a deal with Imprivata with respect to the integration of Imprivata Medical Device Access into Masimo’s Hospital Automation solutions that feature the Root Patient Monitoring and Connectivity Platform.
Market Prospects
Per a report by Grand View Research, the global remote patient-monitoring system market is anticipated to reach $1.8 billion by 2026, witnessing a CAGR of 13.5% during the forecast period (2019-2026). Hence, this launch is well-timed.
Price Performance
Over the past three months, shares of this company have surged 52.3% compared with the industry’s growth of 46.2%.
Zacks Rank and Key Picks
Masimo currently holds a Zacks Rank #3 (Hold).
Some better-ranked stocks from the broader medical space are Laboratory Corporation of America Holdings (LH - Free Report) , Surmodics (SRDX - Free Report) and HMS Holdings .
LabCorp’s long-term earnings growth rate is estimated at 6.1%. The company presently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Surmodics’ long-term earnings growth rate is estimated at 10%. The company presently carries a Zacks Rank #1.
HMS Holdings’ long-term earnings growth rate is estimated at 10%. It currently carries a Zacks Rank #2.
Zacks Top 10 Stocks for 2020
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?
Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Access Zacks Top 10 Stocks for 2020 today >>